Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Sep 17, 2019
Date Accepted: Nov 11, 2019
The Real Era of The Art of Medicine Begins with Artificial Intelligence
ABSTRACT
Physicians have been performing the art of medicine for hundreds of years. The medical profession has always been considered exceptional and highly regarded. Since the ancient era, patients have turned to physicians for help, advice and cures. When the fathers of medicine started writing down their experience, knowledge and observations, treating medical conditions became a structured process with textbooks and professors sharing their methods over generations. After evidence-based medicine was established as the new form of medical science, the art and science of medicine have to be connected. As a result, by the end of the 20th century, healthcare has become highly dependent on technologies. From electronic medical records, telemedicine and 3D printing to algorithms and sensors, technologies started to significantly influence medical decisions and the lives of patients. While digital health technologies can be considered a threat to the art of medicine, I argue that advanced technologies especially artificial intelligence initiate the real era of the art of medicine. Described through the example of a method called reinforcement learning, artificial intelligence could be the stethoscope of the 21st century. If we embrace these tools, the real art of medicine only begins now with the era of artificial intelligence.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.